Zydus Wellness Ltd Q3 FY2026 Concall Summary

Key Takeaways

• Gross margin surged to 63% as the Comfort Click acquisition, which carries structurally higher gross margins, reshaped the portfolio mix; base business brands also expanded gross margins.
• EBITDA margin jumped to 6.3% from 3.2% a year ago, but the base business margin actually declined YoY after adjusting for a one-time GST benefit and field-force investments.
• RiteBite Max Protein is running ahead of plan across value and volume, with standalone EBITDA approaching double digits from breakeven at acquisition, and the brand just launched an RTD product.
• Seasonality hit Nycil and Glucon-D hard: calendar 2025 was the worst season in 6–8 years, forcing the company to absorb trade inventory, and a normal season this year is essential to hitting margin expectations.
• What to watch next quarter: whether the Nycil/Glucon-D season normalizes as the real season begins in March-April, the pace of Complan’s relaunch execution, and any progress on the promised segmental disclosure overhaul.

Portfolio Reshaping: Comfort Click & RiteBite

• Comfort Click integration is tracking to plan with no material surprises in the first four months; due diligence findings have held up, and the acquisition remains cash EPS accretive even after interest and tax.
• D2C performance is ahead of plan, marketplace performance is largely in line, and one or two small operational hiccups have been mostly resolved.
• Repeat purchase rates exceed 50% on marketplaces, which management calls very healthy and characteristic of only a few strong brands; brand ratings sit above 4.6 with market shares in the 8–10% range.
• European expansion is underway with WeightWorld entering Poland, Finland, and Portugal; the U.S. market is also live but still very small.
• India is a lower priority for Comfort Click’s portfolio: Europe and the U.S. are much larger and more similar opportunities, and India will be evaluated at an appropriate time with no near-term plans.
• RiteBite Max Protein continues to significantly outperform internal expectations on both value and volume, retaining leadership in protein snacking; EBITDA has moved from breakeven at acquisition to approaching double-digit margins, supported by innovation, integration synergies, scale benefits, and operational efficiencies.
• Growth is coming from every lever: substantial growth within existing q-commerce and e-commerce platforms, distribution expansion, more sell-through in existing outlets, and new product additions including Wafer Bars and the just-launched RTD.
• International presence has reached 9 countries within the first year, with two additional markets added this quarter.
• The INR500 crore aspirational revenue scale for Max Protein is hypothetically achievable in another two years, per management, and the business is already touching double-digit standalone EBITDA margins.

Arora: "Everything, actually. So we are seeing substantial growth within the platforms we've been existing... we've existed in q-commerce and e-commerce. We are seeing distribution expansion. We are seeing more sell-through through the existing outlets. We have added more products, which have expanded, like we mentioned Wafer Bars and we just launched RTD as we speak."

Base Business: Margin Pressure & Seasonality

• Base business margin declined YoY after excluding Comfort Click and RiteBite, driven by two factors: a ₹9 crore GST budgeting support that was present in the base quarter, and additional expenses from investing in field people.
• Management warns against over-reading quarterly margin moves: margins are so thin (₹10–15 crores) that any ₹5–8 crore incremental spend swings margins by 30–40%; the annual view shows no major impact from these actions.
• Nycil and Glucon-D suffered the worst season in 6–8 years during calendar 2025, with trade channel inventory worse than anything seen before; the company absorbed inventory from retailers and distributors because, as management put it, if product is not selling to a consumer, it is their responsibility.
• A normal or good year for Nycil and Glucon-D is essential for reaching margin expectations; merely improving over the prior year will not be sufficient.
• The first 30 days of the current season are in line with expectations, but the real season starts from March-April, and the company expects to have helped the market clean up inventory with fresh stocks built in by then.
• Everyuth growth was below expectations this quarter, largely due to the Nycil impact, but YTD remains in good double-digit growth; management says a quarter here and there does not matter as underlying trends remain consistent.
• Management reaffirms the 16–17% base business margin target in two years’ time and says current investments will not affect that trajectory.

Arora: "Some of the retail or distributors, we also took a hit and absorbed the inventory because at the end of it, if it is not selling to a consumer, it is our responsibility."

Brand-Level Performance

• Cuticolor, the number one doctor-prescribed brand in hair coloring, has now been initiated into the organized channel for marketing and distribution.
• Complan is expanding celebrity-led outreach by partnering with 14-year-old cricket sensation Vaibhav Suryavanshi.
• Sugar Free launched three new variants this quarter: two gummy variants, one probiotic gummies variant for kids, and Pure Himalayan Shilajit Resin.

Demand Environment & Channel Dynamics

• Consumption trends remained steady, led by sustained recovery in rural demand which continued to outpace gradual improvement in urban markets.
• Quick commerce and e-commerce continue to scale with strong momentum, serving as structural growth drivers across the portfolio.
• Commodity input costs exhibited divergent pricing trends across categories; except for milk, other key inputs remained largely under control ahead of the upcoming season.
• Gross margin expansion was broad-based: most brands recorded gross margin improvement, underscoring portfolio strength, with further support from newly acquired brands.

Financial Mechanics & Disclosure

• The ~3x YoY increase in other expenses is largely due to the inclusion of Comfort Click and RiteBite business expenses; structurally, nothing has changed.
• Comfort Click’s higher marketing spend is variable in nature and linked to digital marketing, which explains the increase in advertisement expenses at the consolidated level.
• A long-term incentive program has been committed for critical employees at Comfort Click.
• The current financial year will be the bottom for EPS, per management; from next financial year onwards, even the newly acquired entity will have an EPS-accretive P&L at the PAT level.
• The team is still finalizing the impact of the revised MAT provisions under the new budget regime; analysis will be ready in about a week’s time.
• Management declined to provide several granular disclosures when pressed by analysts: core legacy business YoY growth excluding acquisitions, Comfort Click constant currency growth rates, base business margins, and specific repeat purchase data for RiteBite were all withheld, with management citing confidentiality and the risk of opening up too much detail.
• Segmental disclosure improvements are coming: management acknowledged the request and committed to working on better visibility over the next few months, by the end of the year.
• Comfort Click constant currency reporting will begin from next year onwards, and a more comprehensive disclosure on Comfort Click metrics will also arrive by the end of the year.

Arora: "No, no, your point is noted, Tejash. We are aware of it. So over the next few months, by end of the year, we'll come back and work on some of these things so that we can give you a better visibility."

Guidance & Commitments

Key Metrics